跳至主要内容
临床试验/NCT01732965
NCT01732965已完成4 期

Prospective Open Parallel Right to Left Bilateral Study Comparing Narrowband Ultraviolet B Alone Versus Narrowband Ultraviolet B and Psoralen Plus Ultraviolet A for the Treatment of Vitiligo

Henry Ford Health System1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2013年3月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
10
试验地点
1
主要终点
Determine the quantity of repigmentation

研究概览

简要总结

To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Vitiligo affecting more than 15% body surface area.

排除标准

  • 未提供

研究组 & 干预措施

NB-UVB phototherapy

Placebo Comparator

NB-UVB alone

干预措施: Phototherapy (Other)

phototherapy and photochemotherapy

Experimental

NB-UVB and PUVA

干预措施: Phototherapy and Photochemotherapy (Other)

结局指标

主要结局

Determine the quantity of repigmentation

时间窗: 6 months

Determination the degree of repigmentation measured by the VASI score (Vitiligo area Scoring Index) after treating with the combination treatments (narrowband ultraviolet B and topical psoralen plus ultraviolet A) and compare it with narrowband ultraviolet B alone.

次要结局

  • Determine the quality of repigmentation.(Study initiation, 3 months and 6 months.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Iltefat Hamzavi

Senior Staff Physician

Henry Ford Health System

研究点 (1)

Loading locations...

相似试验